AstraZeneca Makes Bigger Push into Weight-Loss Market with New Drug Deal
AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company, is making a bigger push into the weight-loss drug market with a new exclusive license agreement with a Chinese company for an obesity and type 2 diabetes pill that is in early stage development. AstraZeneca Makes Bigger Push into Weight-Loss Market with New Drug Deal The deal, […]
AstraZeneca Makes Bigger Push into Weight-Loss Market with New Drug Deal Read More »